文献速递冠心病

非阻塞性冠状动脉心绞痛的内皮分型:一项前瞻性多中心研究

Endotypes of angina with non-obstructive coronary arteries: a prospective multicentre study.
PubMed 文献 · Eur Heart J · 2026-01-01

该研究前瞻性纳入1001例心绞痛但无严重狭窄且FFR>0.80的患者,通过腺苷和乙酰胆碱激发试验评估血流动力学内表型。共识别出8种内表型,其中23%反应正常,12%存在多种内表型,每种内表型与不同临床特征相关,Delphi共识为所有内表型制定了特异性药物治疗方案。

要点

  • 腺苷和乙酰胆碱功能测试可区分8种ANOCA血流动力学内表型。
  • 23%患者功能测试正常,12%存在多种内表型重叠。
  • Delphi共识为每种内表型确定了特异性药物治疗方案。

核心结论

  • 在疑似ANOCA患者中,评估对腺苷和乙酰胆碱的症状、心电图及血流动力学反应可识别不同内表型,实现机制导向的分层治疗。

研究设计与样本

  • 前瞻性多中心研究,连续纳入心绞痛(或等同症状)、无血管造影严重狭窄且FFR>0.80并接受冠状动脉功能测试的患者。
  • 在欧洲和北美9个中心共纳入1001例参与者,平均年龄62±11岁,56%为女性。

主要发现

  • 腺苷测试定义3种内表型:高静息冠脉血流(n=195,19%)、高阻力(n=125,13%)、代偿性高阻力(n=112,11%)。
  • 乙酰胆碱测试定义5种内表型:心外膜冠脉痉挛(n=162,17%)、微血管痉挛(n=75,8%)、内皮功能障碍(n=96,10%)、缺血无血流动力学改变(n=68,7%)、心脏痛觉增强(n=79,8%)。
  • 119例(12%)存在一种以上内表型,234例(23%)反应正常。
  • 每种内表型与不同的临床相关因素相关。

关键数值与推荐

  • Delphi共识(100%「同意」或「强烈同意」)为所有内表型确定了特异性药物治疗,Likert量表评分≥6。

临床怎么用

  • 对疑似ANOCA患者应进行腺苷和乙酰胆碱功能测试以明确内表型。
  • 根据识别的内表型选择相应的特异性药物治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Angina with non-obstructive coronary arteries (ANOCA) is a prevalent myocardial ischaemic syndrome, and women are disproportionately affected. Mechanisms of ischaemia are challenging to diagnose and treatment is empirical. METHODS: Consecutive patients with angina (or equivalent symptoms), no angiographically severe stenosis and fractional flow reserve > 0.80 undergoing coronary functional testing were prospectively enrolled in nine centres in Europe and North America. Haemodynamic endotypes were assessed measuring coronary flow reserve and resistance using an intracoronary pressure- and temperature-sensitive sensor and bolus thermodilution. Measurements were obtained during resting conditions and following adenosine and acetylcholine. Chest pain and electrocardiographic ischaemic changes were recorded. The participant characteristics of each haemodynamic endotype were investigated using regression analysis. A three-step Delphi consensus method was applied to identify endotype-specific therapies. RESULTS: Overall, 1001 participants (mean age 62 ± 11years, 56% female) were enrolled and eight distinct endotypes were defined by adenosine testing (n = 3) and acetylcholine testing (n = 5), respectively: high resting coronary blood flow (n = 195, 19%); high resistance (n = 125, 13%); compensated high resistance (n = 112, 11%); epicardial coronary spasm (n = 162, 17%); microvascular spasm (n = 75, 8%); endothelial dysfunction (n = 96, 10%); ischaemia w/o haemodynamic changes (n = 68, 7%); and enhanced cardiac nociception (n = 79, 8%). More than one endotype occurred in 119 (12%) individuals and normal responses occurred in 234 (23%) individuals. Each endotype was associated with distinct clinical correlates. The Delphi consensus (100% 'agree' or 'strongly agree') identified endotype-specific medical therapy with a Likert scale score ≥ 6 for all endotypes. CONCLUSIONS: In patients with suspected ANOCA, assessment of the symptomatic, electrocardiographic, and haemodynamic responses to adenosine and acetylcholine identifies distinct endotypes and enables mechanism-guided stratified medicine.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Miner S, Mejia-Renteria H, Leone AM, et al. Endotypes of angina with non-obstructive coronary arteries: a prospective multicentre study. Eur Heart J. 2026. PMID: 41214896. doi:10.1093/eurheartj/ehaf839

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。